[1] XIAO XH, TANG JY, MAO YM, et al.Technical guidelines for clinical evaluation of liver injury induced by traditional Chinese medicine[J].Acta Pharmaceutica Sinica(药学学报), 2018, 53(11): 1931-1942. [2] ZHU Y,WANG JB, LI L, et al.Guideline for diagnosis and treatment of herb – induced liver injury[J]. Chinese Journal of Integrated Traditional and Western Medicine(中国中西医结合杂志), 2016, 36(6): 645-653. [3] State Drug Administration. Circular of the State Food and Drug Administration on Issuing the guiding principles for the collection and reporting of individual adverse drug reactions (2018 No. 131)[EB/OL].(2020-09-24) [2022-04-25] .https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20181221172901438.html. [4] AGARWAL VK,MCHUTCHISON JG,HOOFNAGLE JH.Important elements for the diagnosis of drug-induced liver injury[J]. Clinical Gastroenterology and Hepatology, 2010, 8(5): 463-470. [5] ZHU L, REN JT, GUAN W, et al.Analysis of crucial elements in published case reports of drug-induced liver injury[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(11): 663-667. [6] National Standardization Management Committee. GB/T 31774-2015 Coding rules for Chinese medicines and their codes[S] China Standards Press Beijing, 2015. [7] State Drug Administration. Announcement of the state food and drug administration on the issuance of pharmacovigilance quality management specifications (No. 65 in 2021)[EB/OL].(2021-05-07) [2022-04-25].http://www.gov.cn/zhengce/zhengceku/2021-11/29/content_5654764.htm. [8] Medical hepatology group, Hepatology branch, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. Chinese Journal of Hepatology(中华肝脏病杂志), 2015, 23(11): 810-820. [9] YAO KY,CHEN C,ZHU L, et al.Study on literature retrieval and screening scheme assisted by database technology[J]. Chinese Journal of Library and Information Science for Traditional Chinese Medicine(中国中医药图书情报杂志), 2022, 46(3): 1-6. [10] WANG JB, ZHANG L, GUO YM, et al.Causality assessment strategies and methods forChinese medicines-induced liver injury[J].Acta Pharmaceutica Sinica(药学学报), 2018, 53(6): 920-928. [11] LIU Y, ZHOU SX, CHEN NH.Analysis of one case of drug-induced liver injury complicated with type 2 diabetes mellitus[J]. China Pharmacist(中国药师), 2020, 23(10): 1986-1989. [12] QI YT,BAI YH,FENG RQ,et al.Drug induced liver injury complicated with intrahepatic bile duct hamartoma: a case report[J]. Sichuan Medical Journal(四川医学), 2019, 40(2): 211-212. [13] FANG GP, QIAN MY, ZHAI DF, et al.Drug induced liver injury with immune thrombocytopenia: a case report[J]. Chinese Journal of Hepatology(中华肝脏病杂志),2015, 23(10): 786-787. [14] TANG BD.Clinical analysis of a patient with drug-induced liver disease[J]. Journal of China Prescription Drug(中国处方药), 2009(2): 80-81. [15] REN SW, ZHANG J, WANG ZQ.Two cases of severe drug-induced hepatitis[J]. Journal of Practical Hepatology(实用肝脏病杂志), 2008(3): 149. [16] ZHAO Y. Sever liver injury caused by chinese traditional medicine hulisan combined with jieguqilipian in the treatment of patient with rib fracture[J]. Shanghai Medical & Pharmaceutical Journal (上海医药), 2016, 37(6): 39,56. [17] SU L, LI J, LIU HP, et al. A case of abnormal liver function caused by amiodarone tablets combined with zhizhikang capsules[J]. Pharmaceutical Care and Research (药学服务与研究), 2013, 13(5):331, 335. [18] ZHAO HY.Hepatic impairment occurring as a consequence of intravenous infusion of ofloxacin and Shuanghuanglian injection[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2004(3): 198-199. |